TALPHERA, INC.

New Filing
CIK: 0001427925·Pharmaceuticals·DELAWARE·Filed: Sep 15, 2025
Total Offering

$28,969,997

Amount Sold

$16,984,999

Investors

13

First Sale

Sep 10, 2025

Offering Details

Type
Equity, Option to Acquire, Security to be Acquired
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Vincent J Angotti
Related Person
Badri P Dasu
Related Person
Raffi Asadorian
Related Person
Adrian Adams
Related Person
Shakil Aslam
Related Person
Jill Broadfoot
Related Person
Marina Bozilenko
Related Person
Stephen J Hoffman
Related Person
Mark Wan
Related Person
Abhinav Jain
Related Person

Company

ACELRX PHARMACEUTICALS INC

1850 GATEWAY DRIVE

SAN MATEO, CA, 94404

650-216-3500

SEC Filing

0001427925-25-000006

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
TALPHERA, INC. Form D Filing — $28,969,997 | FilingFlow